Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma 9Melanoma 6Hemangioma, Capillary 6Breast Neoplasms 5Sarcoma 3Hemangiosarcoma 3Fallopian Tube Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Hemangioma, Cavernous, Central Nervous System 2Carcinoma, Ovarian Epithelial 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Sarcoma, Kaposi 1Recurrent respiratory papillomatosis 1Recurrence 1Papilloma 1Ovarian Neoplasms 1Neuroblastoma 1

Interventions

Vitamin E 1Taurine 1Standard of Care 1Saline Solution 1Radiotherapy 1Propranolol 1Morphine 1Lysine Acetyltransferase 5 1Electrochemotherapy 1Cryotherapy 1Control Groups 1Bleomycin 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ulcer × Propranolol × Clear all
NCT06798363 2026-03-16

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

West China Hospital

Phase 2/3 Recruiting
40 enrolled

Ulcer, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡